A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment

As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared de...

Full description

Saved in:
Bibliographic Details
Main Authors: Merrill E. Rubens, Timothy P. Mayo, Radhika K. Smith, Sean C. Glasgow, Mary C. Politi
Format: Article
Language:English
Published: Wolters Kluwer Health 2023-12-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000364
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589696347144192
author Merrill E. Rubens
Timothy P. Mayo
Radhika K. Smith
Sean C. Glasgow
Mary C. Politi
author_facet Merrill E. Rubens
Timothy P. Mayo
Radhika K. Smith
Sean C. Glasgow
Mary C. Politi
author_sort Merrill E. Rubens
collection DOAJ
description As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared decision-making (SDM) between patients and clinicians can improve decision quality when patients are faced with preference-sensitive care options. We interviewed 28 stakeholders (13 clinicians and 15 patients) to understand their perspectives on early-stage rectal cancer treatment decision-making. Clinicians included surgeons, medical oncologists, and radiation oncologists who treat rectal cancer. Adult patients included those diagnosed with early-stage rectal cancer in the past 5 years, recruited from an institutional database. A semi-structured interview guide was developed based on a well-established decision support framework and reviewed by the research team and stakeholders. Interviews were conducted between January 2022 and January 2023. Transcripts were coded by 2 raters and analyzed using thematic analysis. Both clinicians and patients recognized the importance of SDM to support high-quality decisions about the treatment of early-stage rectal cancer. Barriers to SDM included variable clinician motivation due to lack of training or perception of patients’ desires or abilities to engage, as well as time-constrained encounters. A decision aid could help facilitate SDM for early-stage rectal cancer by providing standardized, evidence-based information about treatment options that align with clinicians’ and patients’ decision needs.
format Article
id doaj-art-5441e15f0dbe4cd999c973b430cc8e30
institution Kabale University
issn 2691-3593
language English
publishDate 2023-12-01
publisher Wolters Kluwer Health
record_format Article
series Annals of Surgery Open
spelling doaj-art-5441e15f0dbe4cd999c973b430cc8e302025-01-24T09:18:12ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932023-12-0144e36410.1097/AS9.0000000000000364202312000-00030A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer TreatmentMerrill E. Rubens0Timothy P. Mayo1Radhika K. Smith2Sean C. Glasgow3Mary C. Politi4From the * Department of SurgeryFrom the * Department of Surgery† Section of Colon and Rectal Surgery, Department of Surgery† Section of Colon and Rectal Surgery, Department of Surgery‡ Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, MO.As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared decision-making (SDM) between patients and clinicians can improve decision quality when patients are faced with preference-sensitive care options. We interviewed 28 stakeholders (13 clinicians and 15 patients) to understand their perspectives on early-stage rectal cancer treatment decision-making. Clinicians included surgeons, medical oncologists, and radiation oncologists who treat rectal cancer. Adult patients included those diagnosed with early-stage rectal cancer in the past 5 years, recruited from an institutional database. A semi-structured interview guide was developed based on a well-established decision support framework and reviewed by the research team and stakeholders. Interviews were conducted between January 2022 and January 2023. Transcripts were coded by 2 raters and analyzed using thematic analysis. Both clinicians and patients recognized the importance of SDM to support high-quality decisions about the treatment of early-stage rectal cancer. Barriers to SDM included variable clinician motivation due to lack of training or perception of patients’ desires or abilities to engage, as well as time-constrained encounters. A decision aid could help facilitate SDM for early-stage rectal cancer by providing standardized, evidence-based information about treatment options that align with clinicians’ and patients’ decision needs.http://journals.lww.com/10.1097/AS9.0000000000000364
spellingShingle Merrill E. Rubens
Timothy P. Mayo
Radhika K. Smith
Sean C. Glasgow
Mary C. Politi
A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
Annals of Surgery Open
title A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
title_full A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
title_fullStr A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
title_full_unstemmed A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
title_short A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
title_sort qualitative exploration of stakeholders preferences for early stage rectal cancer treatment
url http://journals.lww.com/10.1097/AS9.0000000000000364
work_keys_str_mv AT merrillerubens aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT timothypmayo aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT radhikaksmith aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT seancglasgow aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT marycpoliti aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT merrillerubens qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT timothypmayo qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT radhikaksmith qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT seancglasgow qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment
AT marycpoliti qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment